Dewey Steadman | executive |
Martine Rothblatt | executive |
Michael Benkowitz | executive |
Roanna Clarissa Ruiz | analyst |
Jessica Fye | analyst |
Ashwani Verma | analyst |
James Edgemond | executive |
Joseph Thome | analyst |
Leigh Peterson | executive |
Andreas Argyrides | analyst |
Good morning, everyone, and welcome to the United Therapeutics Corporation Second Quarter 2024 Earnings Webcast. My name is Cole, and I'll be your conference operator today. [Operator Instructions] And please note that this call is being recorded. I would now like to turn the webcast over to Dewey Steadman, Head of Investor Relations, at United Therapeutics. Please go ahead.